Quality and functionality of saffron: Quality control, species assortment and affinity of extract and isolated saffron compounds to NMDA and σ1 (Sigma-1) receptors

Planta Medica

Volumn 74, Issue 7, 2008, Pages 764-772

  Lechtenberg, Matthias ^a   Schepmann, Dirk ^a   Niehues, Michael ^a   Hellenbrand, Nils ^a   Wünsch, Bernhard ^a   Hensel, Andreas ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

1 (sigma 1) receptor; Crocins; Crocus sativus L.; Iridaceae; NMDA receptor; Saffron

Indexed keywords

CIS CROCIN; CROCETIN; CROCIN; CROCUS SATIVUS EXTRACT; HERBACEOUS AGENT; N METHYL DEXTRO ASPARTIC ACID; PICROCROCIN; PLANT GLYCOSIDE; SAFFRON EXTRACT; SIGMA 1 OPIATE RECEPTOR;

ARTICLE; CHROMATOGRAPHY; CROCUS; DRUG DETERMINATION; DRUG ISOLATION; DRUG QUALITY; DRUG RECEPTOR BINDING; FAST CENTRIFUGAL PARTITION CHROMATOGRAPHY; GAS CHROMATOGRAPHY; GOOD MANUFACTURING PRACTICE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; RECEPTOR AFFINITY; SPECIES DIFFERENCE; VALIDATION PROCESS;

CAROTENOIDS; CROCUS; CYCLOHEXANONES; CYCLOHEXENES; FLOWERS; GLUCOSIDES; PLANT EXTRACTS; QUALITY CONTROL; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, SIGMA; REFERENCE STANDARDS; TERPENES;

CROCUS SATIVUS; IRIDACEAE;

EID: 45849129861     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1074535     Document Type: Article

References (22)

1. Schmidt M, Betti G, Hensel A. Saffron in phytotherapy: pharmacology and clinical uses. Wien Med Wochenschr 2007; 157/13-14: 315-9
2. Hensel A, Rösing M. Crocus. In: Blaschek W, Ebel S, Hackenthal E, Holzgrabe U, Seller U, Reichling J, editors. HagerRom: Hagers Handbuch der Drogen und Arzneistoffe Heidelberg (Germany): Thieme Publishers; 2006, Springer Electronic Media
3. Abdullaev F, Frenkel GD. Saffron in biological and medical research In: Negbi, M, editor Saffron. Crocus sativus Amsterdam: Harwood Academic Publishers; 2005: 103-13
4. Akhonzadeh S, Tahmacebi-Pour N, Noorbala AA, Fallah-Pour H, Jamshidi AH, Khani M. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial. Phytother Res 2005; 19: 148-51
5. Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, Jamshidi AH. Hydro-alkoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. J Ethnopharmacol 2005; 97: 281-4
6. Abe K, Saito H. Effects of saffron extract and its constituent crocin on learning behaviour and long-term potentiation. Phytother Res 2000; 14: 149-52
7. Abe K, Sugiura M, Shoyama Y, Saito H. Crocin antagonizes ethanol inhibition of NMDA receptor-mediated responses in rat hippocampal neurons. Brain Res 1998; 787: 32-8
8. Hosseinzadeh H, Sadeghnia HR. Protective effect of safranal on pentylenterazol-induced seizures in the rat: involvement of GABAergic and opioids systems. Phytomedicine 2007; 14: 256-62
9. Bowen WD. Sigma receptors: recent advances and new clinical potentials. Pharm Acta Helv 2000; 74: 211-8
10. Hayashi T, Su TP. Sigma1 receptor ligands: potential in the treatment of neuropsychiatric disorders. CNS Drugs 2004; 18: 269-84
11. Maurice T, Lockhart BP. Neuroprotective and anti-amnesic potentials of sigma receptor ligands. Prog Neuropsychopharmacol Biol Psych 1997; 21: 69-102
12. Wintherhalter P, Straubinger M. Saffron-renewed interest in an ancient spice. Food Rev Int 2000; 16: 39-59
13. Li N, Lin G, Kwan YW, Min ZD. Simultaneous quantification of five major biologically active ingredients of saffron by high-performance liquid chromatography. J Chromatogr A 1999; 849: 349-55
14. Carmona M, Zalacain A, Sánchez AM, Novella JL, Alonso GL. Crocetin esters, picrocrocin and its related compounds present in Crocus sativus stigmas and Gardenia jasminoides fruits. Tentative identification of seven new compounds by LC-ESI-MS. J Agric Food Chem 2006; 54: 973-9
15. Text on Validation of Analytical procedures - ICH Harmonized Tripartite Guideline. ICH; ICH-Q2A. Available at http://www.fda.gov/cder/guidance/ichq2a. pdf. Accessed March 06, 2008
16. Validation of Analytical Procedures: Methodology - ICH Harmonized Tripartite Guideline. ICH; ICH-Q2B. Available at http://www.fda.gov/cder/ guidance/1320fnl.pdf. Accessed March 06, 2008
17. Wirt U, Schepmann D, Wünsch B. Asymmetric synthesis of 1-substituted tetrahydro-3-benzazepines as NMDA receptor antagonists. Eur J Org Chem 2007; 1: 462-75
18. Straubinger M, Bau B, Eckstein S, Fink M, Winterhalter P. Identification of novel glycosidic aroma precursors in saffron (Crocus sativus L.). J Agric Food Chem 1998; 46: 3238-43
19. Straubinger M, Bau B, Eckstein S, Jezussek M, Winterhalter P. Isolation of new saffron constituents using counter-current chromatography. In: Herderich M, Humpf HU, Schwab W, editors. Natural product analysis: chromatography - spectroscopy - biological testing, 1st. edition Wiesbaden: Vieweg Publishers; 1998: 27-34
20. Straubinger M, Jezussek M, Waibel R, Winterhalter P. Novel glycosidic constituents from saffron. J Agric Food Chem 1997; 45: 1678-81
21. Berthod A, Hassoun M, Ruiz-Angel MJ. Alkane effect in the Arizona liquid systems used in countercurrent chromatography. Anal Bioanal Chem 2005; 383: 327-40
22. Xi L, Qian Z, Du P, Fu J. Pharmacokinetic properties of crocin (crocetin digentiobiose ester) following oral administration in rats. Phytomedicine 2007; 14: 633-6